The GLP-1 Revolution: Navigating Injectable Therapy for Diabetes and Weight Management in AmericaIn the landscape of American health care, few pharmaceutical advancements have captured the general public creativity and transformed scientific practice as rapidly as Glucagon-Like Peptide-1 (GLP-1) receptor agonists. Originally established to manage Type 2 diabetes, these injectable therapies
